| Financial Year |
March 31 2023 |
| Monetary Funds |
128,053,558.05 |
| Held-for-trading Financial Assets |
45,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
61,376,433.79 |
| Advances to Suppliers |
7,421,152.44 |
| Other Receivables |
18,606,205.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
98,903,732.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
826,978.00 |
| Total Current Assets |
360,572,137.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
72,296,109.40 |
| Under-construction Projects |
28,723,488.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,685,231.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
291,846.39 |
| Deferred Income Tax Assets |
9,964,617.73 |
| Other Non-Current Assets |
1,849,560.72 |
| Sub-Total of Non-Current Assets |
158,146,331.08 |
| Total Assets |
518,718,468.36 |
| Short-Term Loans |
56,711,353.10 |
| Trading Financial liabilities |
237,200.00 |
| Notes Payable |
-- |
| Accounts Payable |
38,030,096.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,339,248.02 |
| Taxes Payable |
18,968,162.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,408,535.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
32,800.97 |
| Sub-Total of Current Liabilities |
127,196,167.96 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
997,261.81 |
| Deferred Income Tax Liabilities |
2,479,938.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,677,199.82 |
| Total Liabilities |
130,873,367.78 |
| Paid-In Capital(Or Share Stock) |
268,800,000.00 |
| Capital Surplus |
54,826,048.15 |
| Surplus Reserve |
35,990,725.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
45,500,223.60 |
| Minority Stockholder's Interest |
851,590.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
386,993,510.51 |
| Owner's Equity（Stockholder's Equity） |
387,845,100.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
518,718,468.36 |
